Teenage obesity – Xenical orlistat can help

Xenical orlistat Obesity is now a global health phenomenon and one of the most prevalent adolescent health disorders all over the world. Teenage obesity has a number of short as well as long term implications on adolescent health, particularly greater risk of conditions such as high cholesterol levels, high blood pressure and type 2 diabetes. Various studies have also reported that teenage and childhood obesity is closely linked to earlier mortality rates in adulthood.
Xenical orlistat for weight loss in teens
The United States Food and Drug Administration (FDA) has approved the use of  Xenical orlistat in the treatment and management of obesity in adolescents between the ages of 12-16. This happened in December 2003 and is the first FDA approval of its kind, particularly for a prescription anti-obesity medication. This is good news for parents, physicians as well as to adolescents struggling with obesity and associated health conditions. FDA approval for Xenical orlistat for treating teenage obesity is a big step, revolutionizing health care for teenagers.
But it should be noted that this medication needs to be taken as a component of a holistic weight management program that also includes other weight loss measures such as dieting and exercise, along with behavior modification therapy such as cutting down on overeating and binge eating. Researchers have discovered that simply eating less or getting more exercise aren’t enough by themselves. These lifestyle changes have been reported to be much more effective in managing teenage obesity when combined with Xenical.

Tags: ,

Comments are closed.

October 2017
« Aug